Page 123 - 11-Spichak
P. 123
DOI: https://doi.org/10.15414/2020.9788055222974
О.С. Шпичак ‒ Застосування продуктів бджільництва, їх стандартизованих субстанцій
та апіпрепаратів в медицині, фармації та косметології
Laparoscopic repair of perforatedpeptic ulcer: patch versus simple closure / Abd Ellatif
M. E., Salama A. F., Elezaby A. F. [et al.]// Int. J. Surg. – 2013. – Vol. 24. – P. 176-183.
Leane M. A., Pitt K., Reynolds G. proposal for a drug product Manufacturing Classification
System (MCS) for oral solid dosage forms. Pharm. Dev. Technol. 2015.Vol. 20 (1). P.
1-10.
Malhotra M. Effect of preservative, antioxidant and viscolizing agents on in vitro
transcorneal permeation of ketorolac tromethamine. Indian. Journ. Exp. Biol. 2002.
Vol. 40, № 5. P. 555-559.
Mangal T. D., Aylward R. B., Grassly N. C. The potential impact of routine immunization
with inactivated poliovirus vaccine on wild–type or vaccine–derived poliovirus
outbreaks in a posteradication setting. Am. J. Epidemiol. 2013. Vol. 178, № 10. P.
1579–1587.
Medications Used for Acne Vulgaris: Practice Trends and the Use of Topical Combination
Products / E. S. Robin, A. D. Scott,M. L. Michelle,S. R. Feldman // Combination
Products in Therapy. – 2012. – Vol. 2, № 1. – Р. 201–208.
Mehanna M. M. Mucoadhesive liposomes as ocular delivery system: physical,
microbiological, and in vivo assessment. Drug Development and Industrial Pharmacy.
2010. Vol. 36, № 1. P. 108-118.
Mikkola C. FDA Provides new formulation tool. Pharm. Tech. 2003. Vol. 27, № 2. P. 22.
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive,
fast, and standardized technologies / J. J. Van Dongen et al. Blood. 2015. Vol. 125. P.
3996.
Miorin P. L., Levy N. C. Jr., Custodio A. R. Antibacterial activity of honey and propolis from
Apis mellifera and Tetragonisca angustula against Staphylococcus aureus. J. Appl.
Microbiol. 2003. Vol. 95, № 4. P. 913–920.
New methodologies to characterize the effectiveness of the gene transfer mediated by
DNA-chitosan nanoparticles / M. N. Centelles et al. Int. Jour. Nanomedicine. 2008. Vol.
3, № 4. P. 451–460.
Nordström J. The granule porosity controls the loss of compactability for both dry- and
wet-processed cellulose granules but at different rate / Nordström J., Alderborn G.
// J. Pharm. Sci. – 2015. – Vol. 104 (6). – P. 2029-2039.
Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular
hypertension / J. T. Whitson et al. Journ. Ocul. Pharmacol. Ther. 2010. Vol. 26, № 3.
P. 287-292.
Osmolality, osmolarity and osmotic pressure ratio / M. Levin et al. Pharmeuropa. 1999.
Vol. 11, № 3. Р. 22-23.
Perry, A. L. Propionbacterium acnes / A. L. Perry, P. A. Lambert // Lett Appl Microbiol. –
2006. – Vol. 42, № 3. – P. 185–188.
Persistence and adherence with topical glaucoma therapy / B. L. Nordstrom et al. Am. J.
Ophthalmol. 2005. Vol. 140. P. 598–606.
Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract
formulated in softgel capsules / S. Dall'Acqua et al. Eur J Pharm Biopharm. 2015. Vol.
97, (Pt A). Р. 8–14.
Phosphate buffer in alkali eye burns as an inducer of experimental corneal calcification /
N. F. Schrage et al. Burns. 2001. Vol. 27, № 5. P. 459-464.
Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery / H. R. Lin et al.
Journ. Biomater Sci. Polym. Ed. 2007. Vol. 18, № 2. P. 205-221.
rd
Plewig, G. Acne and Rosacea / G. Plewig, A. M. Kligman, J. J. Jansen. 3 ed.. – Berlin :
Heidelberg; N.–Y. : Springer–Verlag, 2000. – 744 p.
123